5//SEC Filing
Soni Rakesh 5
Accession 0001140361-09-002226
CIK 0001228627other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:05 PM ET
Size
14.9 KB
Accession
0001140361-09-002226
Insider Transaction Report
Form 5
Soni Rakesh
Chief Business Officer
Transactions
- Sale
Common Stock
2008-05-27$5.97/sh−300$1,791→ 2,700 total - Purchase
Common Stock
2007-07-06$1.86/sh+1,000$1,860→ 2,000 total - Purchase
Common Stock
2007-12-21$1.50/sh+1,000$1,500→ 3,000 total - Purchase
Common Stock
2007-06-26$1.60/sh+1,000$1,600→ 1,000 total - Award
Non-statutory stock option
2008-12-11+250,000→ 250,000 totalExercise: $0.78Exp: 2018-12-11→ Common Stock (250,000 underlying) - Award
Non-statutory stock option
2008-09-30+300,000→ 300,000 totalExercise: $1.29Exp: 2018-09-30→ Common Stock (300,000 underlying)
Footnotes (3)
- [F1]Each of these transactions occurred prior to Mr. Soni's appointment as an executive officer.
- [F2]These options will vest and become exercisable as to 30% of the options on December 11, 2009; another 30% of the options December 11, 2010; and the remaining 40% of the options on December 11, 2011.
- [F3]These options will vest and become exercisable as to 30% of the options on September 30, 2009; another 30% of the options September 30, 2010; and the remaining 40% of the options on September 30, 2011.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001440181
Filing Metadata
- Form type
- 5
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:05 PM ET
- Size
- 14.9 KB